Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2025CancersOpen Access

Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients—A New Promise? Preliminary Results

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRon BatashNANoam AsnaSASyed Ahsan Ali

Discussion

Loading...

Member takes

Overview

Observational study reports significant pain reduction in oncologic patients with CIPN, suggesting topical treatment may improve outcomes.

Key Points

  • Significant reduction in pain scores from mean VAS of 7 to 3 in CIPN patients treated with a topical cream.
  • Initial mean pain intensity was 7, and 77.14% of evaluable patients reported symptom relief after treatment.
  • Prospective observational study conducted over 28 weeks at Barzilai Medical Center involving 37 oncology patients.
  • Findings indicate a safe and effective option for managing CIPN symptoms, warranting further large-scale trials.

Cite This Study

Batash et al. (2025) studied this question.

synapsesocial.com/papers/68f10ecee6a12fd0428999bbhttps://doi.org/10.3390/cancers17203321
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A topical nociceutical formulation ameliorates chemotherapy-induced peripheral neuropathy: a pilot randomized clinical study2025
  2. 2The Role of the Antidepressants in Managing Chemotherapy‐Induced Neuropathic Pain: A Systematic Review2026
  3. 3Chemotherapy-induced Peripheral Neuropathy: A Mini-review of Current & Developmental Treatments2024
  4. 4Efficacy and Safety of Duloxetine with Gabapentin or Amitriptyline Versus Duloxetine Monotherapy in Chemotherapy-Induced Peripheral Neuropathy: Randomized Controlled Trial2026 · 2 citations
  5. 5A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial2026